United Kingdom · Question · Written question
UIN 22009
Clinical Trials
Introduced
24 June 2021
Last action
2 July 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
2 July 2021
Summary
To ask the Secretary of State for Health and Social Care, what steps the Government plans to take to ensure that the regulation of clinical trials is not weakened as the UK leaves the European Medicines Agency system.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
24 June 2021
Written question
To ask the Secretary of State for Health and Social Care, what steps the Government plans to take to ensure that the regulation of clinical trials is not weakened as the UK leaves the European Medicines Agency system.
Source: Commons
2 July 2021
Answer
The Medicines and Medical Devices Act 2021 provides targeted delegated powers which enable the regulatory regime for clinical trials to be updated. Using these powers we can design and strengthen a regulatory environment for clinical trials that will sup...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-06-24/22009
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1340073
- uk · wq-1340073 · source updated 2 July 2021